Rigel Pharmaceuticals, Inc. (RIGL)

Rigel Pharmaceuticals Market Cap

Rigel Pharmaceuticals has a market cap or net worth of $169.61 million as of July 22, 2024. Its market cap has decreased by -29.74% in one year.

• Market Cap: 169.61M
• Enterprise Value: 180.56M
• 1-Year Change: -29.74%
• Ranking: #3742
• Category: Micro-Cap
• Stock Price: $9.66

Market Cap Chart

Since November 29, 2000, Rigel Pharmaceuticals's market cap has decreased from $254.90M to $169.61M, a decrease of -33.46%. That is a compound annual growth rate of -1.71%.

Market Cap History

Date	Market Cap	% Change
Jul 19, 2024	169.40M	-32.99%
Dec 29, 2023	252.80M	-2.51%
Dec 30, 2022	259.30M	-42.78%
Dec 31, 2021	453.20M	-23.37%
Dec 31, 2020	591.40M	64.87%
Dec 31, 2019	358.70M	-6.42%
Dec 31, 2018	383.30M	-32.57%
Dec 29, 2017	568.40M	141.36%
Dec 30, 2016	235.50M	-12.19%
Dec 31, 2015	268.20M	34.57%
Dec 31, 2014	199.30M	-20.02%
Dec 31, 2013	249.20M	-55.93%
Dec 31, 2012	565.50M	0.60%
Dec 30, 2011	562.10M	43.14%
Dec 31, 2010	392.70M	-20.31%
Dec 31, 2009	492.80M	68.36%
Dec 31, 2008	292.70M	-62.86%
Dec 31, 2007	788.20M	164.67%
Dec 29, 2006	297.80M	47.43%
Dec 30, 2005	202.00M	-57.71%
Dec 31, 2004	477.70M	68.26%
Dec 31, 2003	283.90M	465.54%
Dec 31, 2002	50.20M	-71.28%
Dec 31, 2001	174.80M	-51.24%
Dec 29, 2000	358.50M	40.64%

View and export this data all the way back to 2000. Sign Up Today.

Related Stocks

Company	Market Cap
Fennec Pharmaceuticals	174.59M
Innate Pharma	174.04M
MediWound	172.67M
Acumen Pharmaceuticals	172.43M
OrganiGram Holdings	170.56M
Adverum Biotechnologies	169.58M
Atossa Therapeutics	168.51M
Syros Pharmaceuticals	167.59M